Pilot study of the combination of melphalan, carboplatin and etoposide as a conditioning regimen for relapsed lymphoma patients

被引：5

作者：

del Giglio, A

Costa, LJM

Pinczowski, H

Varella, PCS

Luzzi, JR

Neves, P

Mota, A

Boente, P

Sampaio, C

机构：

[1] ABC Fdn, Sch Med, BR-01444001 Sao Paulo, Brazil

[2] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil

[3] Samaritan Hosp, Blood Bank, Sao Paulo, Brazil

[4] Grp Estud Med, Sao Paulo, Brazil

来源：

ACTA HAEMATOLOGICA | 1999年 / 102卷 / 01期

关键词：

D O I：

10.1159/000040969

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：56 / 58

页数：3

共 13 条

[1] High dose consolidation with autologous stem cell rescue (ASCR) for nephroblastoma initially treated according to the SIOP9/GPOH trial and study [J].

Hempel, L ;

Kremens, B ;

Weirich, A ;

Graf, N ;

Zintl, F ;

Ludwig, R .

KLINISCHE PADIATRIE, 1996, 208 (04) :186-189

[2]

HESS AD, 1993, BONE MARROW TRANSPL, V12, pS65

[3] ACUTE CUTANEOUS ERUPTIONS AFTER MARROW ABLATION - ROSES BY OTHER NAMES [J].

HORN, TD .

JOURNAL OF CUTANEOUS PATHOLOGY, 1994, 21 (05) :385-392

[4]

KUPARI M, 1990, BONE MARROW TRANSPL, V5, P91

[5] SYNERGISTIC CYTOTOXICITY OF DIFFERENT ALKYLATING-AGENTS FOR EPITHELIAL OVARIAN-CANCER [J].

LIDOR, YJ ;

SHPALL, EJ ;

PETERS, WP ;

BAST, RC .

INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (05) :704-710

[6] High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: Non-haematological, haematological toxicities and role of growth factor administration [J].

Panici, PB ;

Pierelli, L ;

Scambia, G ;

Foddai, ML ;

Salerno, MG ;

Menichella, G ;

Vittori, M ;

Maneschi, F ;

Caracussi, U ;

Serafini, R ;

Leone, G ;

Mancuso, S .

BRITISH JOURNAL OF CANCER, 1997, 75 (08) :1205-1212

[7] AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS COMPARED WITH SALVAGE CHEMOTHERAPY IN RELAPSES OF CHEMOTHERAPY-SENSITIVE NON-HODGKINS-LYMPHOMA [J].

PHILIP, T ;

GUGLIELMI, C ;

HAGENBEEK, A ;

SOMERS, R ;

VANDERLELIE, H ;

BRON, D ;

SONNEVELD, P ;

GISSELBRECHT, C ;

CAHN, JY ;

HAROUSSEAU, JL ;

COIFFIER, B ;

BIRON, P ;

MANDELLI, F ;

CHAUVIN, F .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (23) :1540-1545

[8] RESULTS OF A SALVAGE TREATMENT PROGRAM FOR RELAPSING LYMPHOMA - MINE CONSOLIDATED WITH ESHAP [J].

RODRIGUEZ, MA ;

CABANILLAS, FC ;

VELASQUEZ, W ;

HAGEMEISTER, FB ;

MCLAUGHLIN, P ;

SWAN, F ;

ROMAGUERA, JE .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) :1734-1741

[9] THE CYTO-TOXIC ACTIVITY OF CISPLATIN, CARBOPLATIN AND TENIPOSIDE ALONE AND COMBINED DETERMINED ON 4 HUMAN SMALL CELL LUNG-CANCER CELL-LINES BY THE CLONOGENIC-ASSAY [J].

ROED, H ;

VINDELOV, LL ;

CHRISTENSEN, IJ ;

SPANGTHOMSEN, M ;

HANSEN, HH .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (02) :247-253

[10]

VANBESIEN K, 1995, BONE MARROW TRANSPL, V15, P549

← 1 2 →